YAP at the Crossroads of Biomechanics and Drug Resistance in Human Cancer
Biomechanical forces are of fundamental importance in biology, diseases, and medicine. Mechanobiology is an emerging interdisciplinary field that studies how biological mechanisms are regulated by biomechanical forces and how physical principles can be leveraged to innovate new therapeutic strategies. This article reviews state-of-the-art mechanobiology knowledge about the yes-associated protein (YAP), a key mechanosensitive protein, and its roles in the development of drug resistance in human cancer. Specifically, the article discusses three topics: how YAP is mechanically regulated in living cells; the molecular mechanobiology mechanisms by which YAP, along with other functional pathways, influences drug resistance of cancer cells (particularly lung cancer cells); and finally, how the mechanical regulation of YAP can influence drug resistance and vice versa. By integrating these topics, we present a unified framework that has the potential to bring theoretical insights into the design of novel mechanomedicines and advance next-generation cancer therapies to suppress tumor progression and metastasis.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
---|---|
Enthalten in: |
International journal of molecular sciences - 24(2023), 15 vom: 06. Aug. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Huang, Miao [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 14.08.2023 Date Revised 15.08.2023 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3390/ijms241512491 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM360693725 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM360693725 | ||
003 | DE-627 | ||
005 | 20231226083544.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/ijms241512491 |2 doi | |
028 | 5 | 2 | |a pubmed24n1202.xml |
035 | |a (DE-627)NLM360693725 | ||
035 | |a (NLM)37569866 | ||
035 | |a (PII)12491 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Huang, Miao |e verfasserin |4 aut | |
245 | 1 | 0 | |a YAP at the Crossroads of Biomechanics and Drug Resistance in Human Cancer |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.08.2023 | ||
500 | |a Date Revised 15.08.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Biomechanical forces are of fundamental importance in biology, diseases, and medicine. Mechanobiology is an emerging interdisciplinary field that studies how biological mechanisms are regulated by biomechanical forces and how physical principles can be leveraged to innovate new therapeutic strategies. This article reviews state-of-the-art mechanobiology knowledge about the yes-associated protein (YAP), a key mechanosensitive protein, and its roles in the development of drug resistance in human cancer. Specifically, the article discusses three topics: how YAP is mechanically regulated in living cells; the molecular mechanobiology mechanisms by which YAP, along with other functional pathways, influences drug resistance of cancer cells (particularly lung cancer cells); and finally, how the mechanical regulation of YAP can influence drug resistance and vice versa. By integrating these topics, we present a unified framework that has the potential to bring theoretical insights into the design of novel mechanomedicines and advance next-generation cancer therapies to suppress tumor progression and metastasis | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a CRISPR/Cas9 imaging | |
650 | 4 | |a bioengineering | |
650 | 4 | |a biomechanics | |
650 | 4 | |a cancer | |
650 | 4 | |a drug resistance | |
650 | 4 | |a extracellular matrix (ECM) | |
650 | 4 | |a mechanobiology | |
650 | 4 | |a mechanomedicine | |
650 | 4 | |a yes-associated protein (YAP) | |
650 | 7 | |a Transcription Factors |2 NLM | |
650 | 7 | |a Adaptor Proteins, Signal Transducing |2 NLM | |
700 | 1 | |a Wang, Heyang |e verfasserin |4 aut | |
700 | 1 | |a Mackey, Cole |e verfasserin |4 aut | |
700 | 1 | |a Chung, Michael C |e verfasserin |4 aut | |
700 | 1 | |a Guan, Juan |e verfasserin |4 aut | |
700 | 1 | |a Zheng, Guangrong |e verfasserin |4 aut | |
700 | 1 | |a Roy, Arkaprava |e verfasserin |4 aut | |
700 | 1 | |a Xie, Mingyi |e verfasserin |4 aut | |
700 | 1 | |a Vulpe, Christopher |e verfasserin |4 aut | |
700 | 1 | |a Tang, Xin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of molecular sciences |d 2008 |g 24(2023), 15 vom: 06. Aug. |w (DE-627)NLM185552161 |x 1422-0067 |7 nnns |
773 | 1 | 8 | |g volume:24 |g year:2023 |g number:15 |g day:06 |g month:08 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/ijms241512491 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 24 |j 2023 |e 15 |b 06 |c 08 |